Found 403 matching trials
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
PHASE2This research study is testing whether a weekly medication called tirzepati...
Location
Institut de Recherches Cliniques de Montréal
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
PHASE4Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Location
Cleveland Clinic Main Campus
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
PHASE3The study examines the Safety and efficacy study of exenatide once weekly i...
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
N/ACARTIZ is a prospective observational clinical registry of adults in Mexico...
Location
IMSS Clínica Río Magdalena
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
PHASE4This is an investigator initiated, multi-center, open-labelled, superiority...
Location
Duchess of Kent Children's Hospital at Sandy Bay
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
PHASE4This is a prospective study to evaluate effect of Exenatide extended releas...
Location
Diabetes Endocrinology Research Center of WNY
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
PHASE2This study will help determine the effect of Glucagon Like Peptide-1 (GLP-1...
Location
University of Mississippi Medical Center
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
PHASE4The purpose of this study was to determine whether monotherapy treatment wi...
Location
University Medical Center Ljubljana
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
N/AThis study is investigating the effect of a medication called glucagon-like...
Location
Guy's and St Thomas' NHS Foundation Trust
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases